Johnson & Johnson

A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson) (France, Castan et al, January 2022, Therapie)

Organ Donation From a Brain Dead Donor With Vaccine-induced Immune Thrombotic Thrombocytopenia After Ad26.COV2.S: The Risk of Organ Microthrombi (Germany, Uzen et al, November 2021, Transplantation)

VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis (17 November 2021, Blood Advances)

Vaccine-Induced Thrombotic Thrombocytopenia Following Coronavirus Vaccine: A Narrative Review, (28 October 2021, Annals of Medicine and Surgery)

Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male (U.S, 14 October 2021, Hussain et al, Case Reports in Critical Care)

Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination (Johnson & Johnson) , (U.S, October 2021, Annals of Emergency Medicine)

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia (28 September 2021, van Kammen et al, JAMA Neurology)

Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination (Austria, 27 August 2021, Gelbenegger et al, Vaccines)

Myocarditis Temporally Associated With COVID-19 Vaccination (U.S,10 August 2021, Circulation)

Temporal association between the COVID-19 Ad26.COV2.S vaccine and acutemyocarditis: A case report and literature review (U.S 9 August 2021, Sulemankhil et al, Cardiovascular Revascularization Medicine)

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far? (U.S, 18 July 2021, Das et al, Children)

Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine (U.S, 25 June 2021, Malik et al, BMJ Case Reports)

Vaccine‐induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism (U.S, 3 June 2021, Abou‐Ismail et al, American Journal of Hematology)

Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination (U.S, 25 May 2021, Yocum et al, American Journal of Emergency Medicine)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination (U.S, 20 May 2021, New England Journal of Medicine)

Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy (U.S, 31 May 2021, American Journal of Haematology)

Reports of cerebral venous sinus thrombosis with thrombocytopenia after Janssen COVID-19 vaccine – Advisory Committee on Immunization Practices (ACIP) April 14, 2021